文献速递肝胆胰外科围术期管理与 ERAS

术后早期动脉血乳酸用于分层肝切除后肝衰竭风险

Early postoperative arterial lactate concentrations to stratify risk of post-hepatectomy liver failure.
PubMed 文献 · Br J Surg · 2021-01-01

这项多中心观察性研究评估了围术期乳酸动态对肝切除后临床相关肝衰竭(CR-PHLF)及并发症的预测价值。探索队列509例中,24小时内最大乳酸(Lactate_Max)预测CR-PHLF的AUC为0.829,术后第1天乳酸(Lactate_POD1)AUC为0.870;验证队列482例中对应AUC分别为0.812和0.751,且Lactate_Max最佳截断值在两队列一致。Lactate_Max≥50 mg/dl者CR-PHLF发生率50.0%,显著高于20–49.9 mg/dl组的7.4%和<20 mg/dl组的0.5%(P<0.001)。

要点

  • 术后24小时内最大动脉血乳酸可强预测临床相关肝衰竭及死亡、严重并发症。
  • Lactate_Max≥50 mg/dl者CR-PHLF发生率50.0%,远高于较低乳酸水平者。
  • 联合Lactate_Max与Lactate_POD1可进一步提高预测AUC(ΔAUC=0.053)。

核心结论

  • 术后早期乳酸值是预测肝切除后临床相关肝衰竭及相关并发症的有力且易得标志物,可能指导术后管理。

研究设计与样本

  • 多中心观察性研究,探索队列509例,验证队列482例(国际高容量中心),共991例患者。

主要发现

  • 探索队列CR-PHLF、死亡、总体并发症和严重并发症发生率分别为7.7%、3.3%、40.9%和29.3%。
  • 探索队列Lactate_Max预测CR-PHLF的AUC为0.829(95%CI 0.770–0.888),Lactate_POD1的AUC为0.870(95%CI 0.818–0.922)。
  • 验证队列Lactate_Max和Lactate_POD1的AUC分别为0.812和0.751,Lactate_Max最佳截断值在两队列一致。
  • 探索队列Lactate_Max≥50 mg/dl者CR-PHLF发生率为50.0%,20–49.9 mg/dl组为7.4%,<20 mg/dl组为0.5%(P<0.001)。
  • Lactate_Max、大范围肝切除、年龄、肝硬化和慢性肾病是CR-PHLF的独立危险因素。

关键数值与推荐

  • Lactate_Max≥50 mg/dl者CR-PHLF发生率50.0%,20–49.9 mg/dl组7.4%,<20 mg/dl组0.5%(P<0.001)。
  • 对应死亡发生率分别为18.4%、2.7%和1.4%,严重并发症分别为71.1%、35.7%和14.1%。
  • 急性肾损伤发生率分别为26.3%、3.1%和2.3%,出血分别为15.8%、3.1%和1.4%。
  • 联合Lactate_Max与Lactate_POD1的ΔAUC=0.053。
  • 提供免费在线计算器(www.liver-calculator.com)辅助临床风险分层。

临床怎么用

  • 术后24小时内监测动脉血乳酸最大值,可帮助识别CR-PHLF高危患者。
  • 高乳酸患者可考虑加强观察、预防性治疗或调整术后护理强度。
  • 结合Lactate_Max与Lactate_POD1动态变化及在线计算器进行综合风险评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Post-hepatectomy liver failure (PHLF) represents the major determinant for death after liver resection. Early recognition is essential. Perioperative lactate dynamics for risk assessment of PHLF and associated morbidity were evaluated. METHODS: This was a multicentre observational study of patients undergoing hepatectomy with validation in international high-volume units. Receiver operating characteristics analysis and cut-off calculation for the predictive value of lactate for clinically relevant International Study Group of Liver Surgery grade B/C PHLF (clinically relevant PHLF (CR-PHLF)) were performed. Lactate and other perioperative factors were assessed in a multivariable CR-PHLF regression model. RESULTS: The exploratory cohort comprised 509 patients. CR-PHLF, death, overall morbidity and severe morbidity occurred in 7.7, 3.3, 40.9 and 29.3 per cent of patients respectively. The areas under the curve (AUCs) regarding CR-PHLF were 0.829 (95 per cent c.i. 0.770 to 0.888) for maximum lactate within 24 h (Lactate_Max) and 0.870 (95 per cent c.i. 0.818 to 0.922) for postoperative day 1 levels (Lactate_POD1). The respective AUCs in the validation cohort (482 patients) were 0.812 and 0.751 and optimal Lactate_Max cut-offs were identical in both cohorts. Exploration cohort patients with Lactate_Max 50 mg/dl or greater more often developed CR-PHLF (50.0 per cent) than those with Lactate_Max between 20 and 49.9 mg/dl (7.4 per cent) or less than 20 mg/dl (0.5 per cent; P < 0.001). This also applied to death (18.4, 2.7 and 1.4 per cent), severe morbidity (71.1, 35.7 and 14.1 per cent) and associated complications such as acute kidney injury (26.3, 3.1 and 2.3 per cent) and haemorrhage (15.8, 3.1 and 1.4 per cent). These results were confirmed in the validation group. Combining Lactate_Max with Lactate_POD1 further increased AUC (ΔAUC = 0.053) utilizing lactate dynamics for risk assessment. Lactate_Max, major resections, age, cirrhosis and chronic kidney disease were independent risk factors for CR-PHLF. A freely available calculator facilitates clinical risk stratification (www.liver-calculator.com). CONCLUSION: Early postoperative lactate values are powerful, readily available markers for CR-PHLF and associated complications after hepatectomy with potential for guiding postoperative care.Presented in part as an oral video abstract at the 2020 online Congress of the European Society for Surgical Research and the 2021 Congress of the Austrian Surgical Society. Liver failure represents a major complication after liver resection and determines the risk of postoperative death, therefore early anticipation and risk stratification are highly relevant. This study, of 991 patients in three international centres, shows that the maximum lactate blood level within 24 h after surgery is a very strong factor predicting the further course after liver operations. Lactate could potentially aid in clinical decision making such as prophylactic treatment, intensified observation or early discharge of patients.

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. Niederwieser T, Braunwarth E, Dasari BVM, et al. Early postoperative arterial lactate concentrations to stratify risk of post-hepatectomy liver failure. Br J Surg. 2021. PMID: 34694377. doi:10.1093/bjs/znab338

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。